3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Sarcoma
14
Osteosarcoma
9
Drug-Related Side Effects and Adverse Reactions
4
Gastrointestinal Stromal Tumors
2
Uterine Neoplasms
1
Neoplasms, Connective and Soft Tissue
1
Neoplasm Metastasis
1
Liposarcoma
1
Head and Neck Neoplasms
1
Chordoma
1
Chondrosarcoma
1
Carcinosarcoma
1
Carcinoma
1
Interventions
Ifosfamide
5
Filgrastim
5
Doxorubicin
5
Gemcitabine
4
Docetaxel
4
Radiotherapy
3
Proton Therapy
3
Carboplatin
3
regorafenib
2
ivosidenib
2
enasidenib
2
belinostat
2
Sunitinib
2
Peripheral Blood Stem Cell Transplantation
2
Nivolumab
2
Immune Checkpoint Inhibitors
2
HhAntag691
2
Fluorouracil
2
Etoposide
2
Epirubicin
2
Cyclophosphamide
2
Cisplatin
2
Chemotherapy, Adjuvant
2
Celecoxib
2
Bevacizumab
2
venetoclax
1
toripalimab
1
temsirolimus
1
tazemetostat
1
tanespimycin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Chondrosarcoma
×
apatinib
×
Sarcoma
×
Clear all
NCT04260113
2021-01-05
AIAC
Peking University People's Hospital
Phase NA
Completed
40 enrolled